800 million people worldwide struggle with obesity, a disease poised to cost over $1 trillion in medical consequences by 2025. Over 40% of the US population is impacted, according to the Centers for Disease Control. Obesity is a major risk factor in the development of illnesses that lead to diabetes, such as insulin resistance, hypertension, and other metabolic disorders. Long-term disrupti...

Introduction The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes. The key to understanding the relationship between diabetes and these other areas begins with the role of energy homeostasis in diabetes. At the same time, investig...

Pancreatic Elastase (PE) Testing for Determination of Exocrine Pancreatic Insufficiency (EPI) Advantages of ALPCO PE Testing for Determination of EPI • No interference from PERT • Single sample collection without dietary restriction • Detection of both CELA3A and CELA3B isoforms • Compatibility with current clinical cut-offs • FDA Class I Device. For In Vitro Diagnostic Use. • Accura...

Melatonin is an endogenously expressed hormone present in a wide spectrum of organisms from bacteria to humans.  Primarily secreted by the pineal gland, melatonin enters the circulation via cerebrospinal fluid and plays a key role in the regulation of the sleep-wake cycle.  Melatonin levels help modulate mood, reproduction, and immune system activities.  The rise and fall of circulating level...

Chromoa® The Chromoa® Chromogranin A ELISA from Cisbio Bioassays is for the quantitative determination of CgA in serum and plasma. The patented monoclonal detection system provides superior specificity, sensitivity and reproducibility to determine elevated serum CgA levels. Above all, the hook effect that is typically seen in other CgA assays is not present, thereby providing you with confiden...